2024 Spasticity Management 101 - Special Considerations-Pediatric Hypertonia Management

Video Transcription

Video Summary

The presentation by Dr. Katie Zurbach and Dr. Patricia Orm covered various aspects of pediatric hypertonia management. They reviewed commonly used oral antispasticity medications like Baclofen, Diazepam, and Clonidine, noting their formulations, age approvals, and side effects. They also discussed botulinum toxin injections, noting Onabotulinum toxin and Abobotulinum toxin use in pediatric upper and lower limb spasticity and the specifics of dosage and FDA approvals. <br /><br />Furthermore, the presentation covered important neurosurgical interventions, including intrathecal Baclofen pumps, selective dorsal rhizotomy (SDR), and combined ventral dorsal rhizotomy. Each procedure's benefits, risks, and patient suitability were detailed, such as the ideal ages, conditions (spasticity vs. dystonia), and post-surgical rehabilitation needs. SDR is particularly beneficial for children with spastic diplegic cerebral palsy, while combined rhizotomy and intrathecal Baclofen are more appropriate for broader conditions including dystonia, especially where frequent medical follow-ups are a challenge.<br /><br />Overall, this comprehensive review emphasized tailored treatment plans considering patient-specific factors, such as spasticity vs. dystonia, age, weight, and logistics, like access to follow-up care.

Keywords

pediatric hypertonia

antispasticity medications

botulinum toxin

neurosurgical interventions

Baclofen pumps

selective dorsal rhizotomy

dystonia management